verified SJR 0,291 · Q3 • database Scopus / SJR & Web of Science & DOAJ indexed

United States · John Wiley and Sons Ltd

workspace_premium Q3 — Infectious Diseases verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Advances in Virology

Advances in Virology is a journal indexed in SJR in Infectious Diseases and Virology with an H index of 32. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 922,5 €. The scope of the journal is focused on microbiology, virology. It has an SJR impact factor of 0,291 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,291.

ISSN: 1687-8639

Publisher: John Wiley and Sons Ltd

Category: Infectious Diseases

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,291 Q3

H-index 32

Acceptance rate pie_chart

37%

Source Acceptance_Rate

Time to publication hourglass_top

22 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

923 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,291

H-index

Docs (year)

Docs 3y

Total refs

550

Cites 3y

Citable 3y

Cites/Doc 2y

1.44

Ref/Doc

55.0

Immediate OA

922,5 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine

XMRV Discovery and Prostate Cancer-Related Research

Epstein-Barr Virus- (EBV-) Immortalized Lymphoblastoid Cell Lines (LCLs) Express High Level of CD23 but Low CD27 to Support Their Growth

Epstein-Barr Virus as a Trigger of Autoimmune Liver Diseases

Endocytosis of Integrin-Binding Human Picornaviruses

Emergence of Hepatitis B Virus Genotype F in Aligarh Region of North India

Elucidating the Interacting Domains ofChandipuraVirus Nucleocapsid Protein

Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?

Direct Detection and Identification of Enteroviruses from Faeces of Healthy Nigerian Children Using a Cell-Culture Independent RT-Seminested PCR Assay

Detection of Influenza Virus Infection Using Two PCR Methods

Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells

Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia

SHOW MORE ARTICLES

Comment on "Emergence of Hepatitis B Virus Genotype F in Aligarh Region of North India"

A Cross-Study Biomarker Signature of Human Bronchial Epithelial Cells Infected with Respiratory Syncytial Virus

Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors

Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea Pigs

Artificial 64-Residue HIV-1 Enhancer-Binding Peptide Is a Potent Inhibitor of Viral Replication in HIV-1-Infected Cells

Arenavirus Budding

Apoptotic and Early Innate Immune Responses to PB1-F2 Protein of Influenza A Viruses Belonging to Different Subtypes in Human Lung Epithelial A549 Cells

Antiviral and Virucidal Activities of N-Cocoyl-L-Arginine Ethyl Ester

Analysis of Nucleotide Alterations in the E6 Genomic Region of Human Papillomavirus Types 6 and 11 in Condyloma Acuminatum Samples from Brazil

Alternanthera mosaic potexvirus: Several Features, Properties, and Application

Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies

Adapted Lethality: What We Can Learn from Guinea Pig-Adapted Ebola Virus Infection Model

FAQs

Advances in Virology has an SJR of 0,291 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 922,5 EUR.

The acceptance rate recorded for Advances in Virology is 37%.

Advances in Virology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Advances in Virology?

What is the APC / publication cost?

What is the acceptance rate?